Abstract:BACKGROUND: The glial scar formation after spinal cord injury in mammals is the physical and chemical barriers for neural regeneration, and relieving or delaying glial scar formation can provide benefit conditions for the regeneration of injured spinal cord.OBJECTIVE: To design and screen short hairpin RNA (shRNA) interfere molecular targeting the gene coding region of glial fibrillary acidic protein (GFAP) in rat, and reconstruct the eukaryotic vector of shRNA.DESIGN: An observational animal experiment.SETTING: Department of Spine Surgery, Shenzhen Hospital affiliated to Southern Medical University.MATERIALS: Twenty-five Wistar rats of clean degree, either male or female, weighing 20-25 g, were used. DMEM/F12,lipofectamine2000, Trizol RNA separating kits); fetal bovine serum (Hyclone); BamH Ⅰ, HindⅢ, Pstl, Sail and T4 ligases;Plasmid mini preparation kit and DNA gel extraction kit.METHODS: The experiments were carried out in the Shenzhen Hospital affiliated to Southern Medical University from October 2005 to June 2006. Three pairs of shRNA template which composed of 19 bp reverse repeated motif of GFAP target sequence with 9 bp spacer were designed and synthesized, then they were inserted directionally into plasmid Psilencer 2.1 respectively to generate small interfering RNA (siRNA) eukaryotic expression vector. ShRNA molecules were transfected by liposome via ex vivo expression repressive model of GFAP of rat spinal astrocytes. The effects of expressive suppression were detected with real-time fluorescence quantitative reverse transcription-polymerase chain reaction (RT-PCR) and Western blot, and then the optimal shRNA eukaryotic vector of repressive expression of GFAP was screened.MAIN OUTCOME MEASURES: ① Interfering sequence specific shRNA template synthesis; ② Constructing specific recombinant plasmid eukaryotic expression vector. ③ Culturing rat spinal astrocytes in vitro; ④ Effects of expressive suppression on GFAP in primary astrocytes after RNA interference detected with real-time fluorescence quantitative RT-PCR and Western blot.RESULTS: Sequence analysis showed that GFAP-shRNA recombinant plasmid eukaryotic expression vector was successfully constructed, and optimal GFAP-shRNA eukaryotic vector was screened using real-time fluorescence quantitative RT-PCR and Western blot. The GFAP expressions were reduced by 81%, 63% and 56% at the levels of mRNA and protein respectively.CONCLUSION: GFAP-shRNA eukaryotic expression vectors were successfully constructed and screened. The gene expression GFAP of primitive rat astrocyte can be suppressed significantly by the GFAP-shRNA eukaryotic expression recombinant optimized via ex vivo cellular expression suppression model, which should pave the way for the following multiple targets of RNAi genetic manipulation in the treatment of suppression of glial scar formation after spinal cord injury.

[Construction of Shrna Lentivirus Vector on Rat DREAM Gene and Its Analgesic Effect on CCI Rats].

Effects of Intrathecal DREAM-shRNA on Expression of P-Creb in Spinal Dorsal Horn in a Rat Model of Neuropathic Pain

Analgesic Effect of Intrathecal DREAM-shRNA in Rats with Neuropathic Pain

Effect of sciatic nerve pulsed radiofrequency glial activation levels in spinal dorsal horn in chronic constriction injury rat models and its analgesia effect

Roles of GALR1 in curing neuropathic pain of rats suffered from CCI through DREAM silencing mediated by lentivirus

Gene Therapy by Lentivirus-Mediated RNA Interference Targeting Extracellular-Regulated Kinase Alleviates Neuropathic Pain in Vivo

Virus-mediated Shrna Knockdown of Na(v)1.3 in Rat Dorsal Root Ganglion Attenuates Nerve Injury-Induced Neuropathic Pain.

Effect of Lentivirus Expressing TLR4 Shrna on Function of Rat Alveolar Macrophage

The Construction of Lentiviral-delivery Human Interleukin-10 Expression Vector and the Abirritative Effect of Pain on CCI Rats

Effect of lentiviral vector-mediated GDNF up-regulation on neuropathic pain of chronic constriction injury rats

Construction and identification of a lentiviral vector for RNA interference of rat chondroitin sulfate peoteoglycan gene

Lentivirus Mediated Sirna Against GluN2B Subunit of NMDA Receptor Reduces Nociception in a Rat Model of Neuropathic Pain

Analgesic Effect of Intrathecal Injection of rAAV/hPPE in Rats with Chronic Neuropathic Pain

Construction and Identification of a Recombinant Lentiviral Vector Encoding Shrna Targeting Rat CBP Gene

Optimal Screening of Short Hairpin and Construction of Its Eukaryotic Expression Vector for Glial Fibrillary Acidic Protein

Optimal Screening of Shrna Molecules and Reconstruction of the Shrna Eukaryotic Expression Vector of GFAP Expressive Suppression of Rat Spinal Cord-Derived Astrocytes

Lentiviral‑mediated Inducible Silencing of TLR4 Attenuates Neuropathic Pain in a Rat Model of Chronic Constriction Injury.

Intrathecal Lentiviral-Mediated Rna Interference Targeting Pkc Gamma Attenuates Chronic Constriction Injury-Induced Neuropathic Pain In Rats

Construction and Identification of Lentivector Encoding Rat δ Opioid Receptor shRNA and Human Preproenkephalin Gene

PREPARATION OF FUNCTIONALIZED SINGLE-WALLED CARBON NANOTUBES/NR2B-SHRNA INTERFERENCE PLASMID COMPLEX AND ITS APPLICATION IN GENE THERAPY FOR CHRONIC PAIN

Construction and Identification of RNAi Lentiviral Vector Targeting Rat Recombination Activating Gene 1